SUPPLY AGREEMENT BETWEEN BIOMEDICA Life Sciences, S.A. AND MOLECULAR INSIGHT PHARMACEUTICALS, INC. dated as of October 19, 2009Supply Agreement • March 10th, 2010 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations
This supply agreement (“Agreement”), dated this 19th day of October, 2009 (the “Effective Date”) is entered into by and between Molecular Insight Pharmaceuticals, Inc. (referred to herein as “MIP”), a corporation organized and existing under the laws of The Commonwealth of Massachusetts and having its principal office at 160 Second Street, Cambridge, MA 02142 USA, and BIOMEDICA Life Sciences S.A., a corporation organized and existing under the laws of Greece, with offices at 4 Papanikoli Str., 15232 Halandri, Athens, Greece (referred to herein as “BIOMEDICA”), with Greek Tax ID of EL 094413470, from the tax office of FAEE Athens; each a “Party” and collectively the “Parties” hereto.
FACILITY SETUP AND CONTRACT MANUFACTURING AGREEMENT between Eckert & Ziegler Nuclitec GmbH Gieselweg 1 38110 Braunschweig Germany - hereinafter referred to as EZN - and Molecular Insight Pharmaceuticals, Inc Cambridge, MA 02142 USA - hereinafter...Facility Setup and Contract Manufacturing Agreement • March 10th, 2010 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations
Azedra Commercial Facility and Supply Agreement THIS AGREEMENT made in duplicate as of this 6th day of August, 2009Quality Agreement • March 10th, 2010 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Ontario
NOW THEREFORE in consideration of the mutual covenants and agreements herein contained, and subject to the terms and conditions hereinafter set out, the parties hereto agree as follows:
